Fundamental Valuation Report Intercept Pharmaceuticals(ICPT:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$19.78 (USD) 04/30/2021 Weighted Valuation$10.32 (USD) Overall RatingOvervalued by 47.8% Valuation Models Comparables: $10.32 (USD) Valuation Methods …

Intercept Pharmaceuticals (ICPT:NAS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report Chimerix(CMRX:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$8.25 (USD) 04/21/2021 Weighted Valuation$6.79 (USD) Overall RatingOvervalued by 17.8% Valuation Models Comparables: $6.79 (USD) Valuation Methods This …

Chimerix (CMRX:NAS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report Array BioPharma(ARRY:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$17.53 (USD) 18/01/2019 Weighted Valuation$23.36 (USD) Overall RatingUndervalued by 33.2% Valuation Models Analyst Consensus: $30.00 (USD) (in …

Array BioPharma (ARRY:NAS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report Array BioPharma(ARRY:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$13.70 (USD) 24/10/2018 Weighted Valuation$22.50 (USD) Overall RatingUndervalued by 64.3% Valuation Models Analyst Consensus: $26.00 (USD) (in …

Array BioPharma (ARRY:NAS) Fundamental Valuation Report Read more »

Read More